Daily Headlines

PUTTING BREAKING MEDICAL NEWS INTO PRACTICE^™

Thursday April 03, 2008

TODAY'S HEADLINES
Add us to your address book or trusted sender list to help ensure delivery.

Did you know that you can earn CME/CE credit by reading our news reports? Look for the CME designation after the article title.

ACC: Rimonabant Therapy Fails to Demonstrate Atherosclerosis Benefit

CHICAGO -- Reducing abdominal obesity with the investigational diet drug rimonabant had a beneficial effect on metabolic profile, but did not demonstrate a significant reduction in percent atheroma volume on intravascular ultrasound, researchers reported here. full story

http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8970

Lung Cancer Investigator Admits Funding by Tobacco Money
BOSTON -- Claudia I. Henschke, M.D., Ph.D., principal investigator of the controversial 2006 I-ELCAP (International Early Lung Cancer Action Program) study, has admitted that tobacco-industry money funded the study. full story

http://www.medpagetoday.com/Pulmonary/LungCancer/tb/9002

Gene Behind Vitamin B12 Disorder Identified

BASEL, Switzerland -- A rare but devastating disorder of vitamin B 12 metabolism arises from mutations in a gene that controls intracellular processing of the vitamin, investigators here found. full story

http://www.medpagetoday.com/Genetics/GeneralGenetics/tb/9000

Neuropsychiatric Symptoms, Deaths Prompt Labeling Changes for Relenza
PHILADELPHIA -- Reports of neurologic symptoms and abnormal behavior, including some deaths, in patients using neuraminidase inhibitors, prompted an update of the package insert for zanamivir (Relenza), GlaxoSmithKline announced in a letter to healthcare professionals. full story

http://www.medpagetoday.com/ProductAlert/Prescriptions/tb/8999

Study Details Heart Risks from HIV Drugs

COPENHAGEN -- Just days after the FDA warned that two HIV drugs may increase the risk of heart attack, leaders of a major observational study have filled in the details. full story

http://www.medpagetoday.com/HIVAIDS/HIVAIDS/tb/8997

More Heparin Recalled Because of Contamination
ROCKVILLE, Md. -- Another U.S. heparin maker, Covidien, has recalled 32 lots of its pre-filled heparin syringes because of contamination with a heparin-like molecule, the FDA announced. full story

http://www.medpagetoday.com/ProductAlert/Prescriptions/tb/8996

ACC: Significant Weight Loss Seen with Experimental Taranabant

CHICAGO -- More than half of patients taking the experimental drug taranabant, combined with diet and exercise, lost 5% of their body weight, researchers reported here. full story

http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8971

ACC: MI Not Automatic Indication for Home Defibrillator

CHICAGO -- For moderate-risk post-MI patients, automated external defibrillators need not be a prominent part of the living room d�cor because they are so infrequently needed, researchers said here. full story

http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8986

ACC: Anxiety May Worsen Prognosis for Coronary Artery Disease

CHICAGO -- In patients with coronary artery disease, lower levels of anxiety may be associated with better cardiovascular health, a prospective cohort study showed. full story

http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8994

ACC: Early Tirofiban Improves Outcomes After PCI

CHICAGO -- In patients suffering an ST-elevation myocardial infarction, treatment with tirofiban (Aggrastat) before getting to the hospital can improve outcomes, according to results from a multicenter randomized trial. full story

http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8993

ACC: Transfer to PCI-capable Hospital Lessens Post-MI Events

CHICAGO -- Giving patients with acute myocardial infraction fibrinolytics and then transferring them to a facility that performs percutaneous coronary interventions prevents serious complications, researchers reported here. full story

http://www.medpagetoday.com/MeetingCoverage/ACCMeeting/tb/8992

CME SPOTLIGHT

Lifelong Management of Parkinson's Disease: Diagnosis, Treatment and Emerging Therapies
A continuing education activity for physicians and pharmacists Update your knowledge on early and advanced stage Parkinson's disease (PD). Learn to assess neurobehavioral disorders in PD patients, review appropriate therapeutic options and plan optimal care of the PD patient.
Source: AAF-MED [more]

Controversies and Consensus in the Management of HIV: Interactive Debates
Are NNRTI- or PI-based regimens the best choice for initial ARV therapy? If a patient is failing therapy, when should you switch? Do treatment experienced patients require 2 or 3 active ARV agents? Join us for thoughtful debates and lively discussion led by a panel of HIV experts.
Source: AdvancMed [more]

Targeted Cancer Therapy From Trial To Clinic
Join Drs. Balducci, Atkins, Cantley, and Herbst for an innovative and in-depth CME-certified Activity on how integration of targeted and conventional therapies for treating cancer is improving patient outcomes.
Source: The Physicians Academy For Clinical and Management Excellence [more]

Taking the Path of Least Resistance to Improved Clinical Outcomes from Surgical Site Infections
Join Dr. Sawyer for an innovative and in-depth CME-certified Activity on taking the path of least resistance to improve clinical outcomes from surgical site infections.
Source: CME Enterprise [more]

Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
This CME/CE program features state-of-the-science information on hepatitis B virus (HBV) disease burden, HBV replication and transmission, screening for HBV, treatment options and management of HBV.
Source: Projects In Knowledge [more]

Genital HPV and HPV Vaccines: Winning acceptance among adolescents and their parents
HPV is a highly prevalent sexually transmitted infection, most common in sexually active women under the age of 25. The following free educational activity is designed to educate physicians about the most common types of genital HPV and review the safety and efficacy of utilizing HPV vaccines.
Source: SciMed New York [more]

neuroscienceCME Journal Club
Trouble keeping up with the latest findings from the clinical literature? neuroscienceCME Journal Club can help. Hear leading authors talk about just-published articles, and then answer your questions. Hosted by Thomas Roth, PhD.
Source: CME Outfitters [more]

Impact of ADHD and Its Treatment on Substance Abuse
Join Dr. Timothy Wilens in an in-depth CME activity as he discusses emerging data on the impact of ADHD and its treatment on substance use disorder, especially as related to adolescents and adults.
Source: The Physicians Academy For Clinical and Management Excellence [more]

Advances in IBD: Natural History, Current Treatment, and Future Directions
Stephen B. Hanauer, MD, and The IBD Institute, review strategies to optimize treatment outcomes with the use of biologic therapy in adult and pediatric patients with IBD.
Source: University of Pennsylvania School of Medicine [more]

JOURNAL DOWNLOADS

First-line SUTENT® data recently published in NEJM
Read first-line SUTENT data in the New England Journal of Medicine. Get it at SUTENThcp.com Source: Pfizer [more]

Efficacy Data for CTCL Published in JCO
Efficacy Data for CTCL Published in JCO. Source: Merck. [more]

RESOURCES

Why not provide greater LDL-C efficacy for your appropriate newly initiated patients?
View the data on 50% mean reduction right from the start. Source: Merck [more]

Frequently painful. Potentially severe. Learn why your patients may be at risk.
Zoster: How Many of your patients are at risk? Source: Merck [more]

Take a closer look at all 3 major lipids and cardiovascular risk. HDL, LDL and TG levels may be independently associated with cardiovascular risk.
Visit www.totallipids.com, a new source of information for health care professionals, about dyslipidemia, all 3 lipids, and cardiovascular risk. Source: Merck [more]

Featured Job Opportunities from MedJobs Today

Urology, Arkansas
Position consists of clinic, hospital consults, and surgery, and there is ER coverage with a minimum of 10 days per month.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17311&refsrc=dh
Urology, New York
A teaching facility in upstate New York is seeking two urologists to place for clinic and call coverage.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17590&refsrc=dh
Urology, Wisconsin
This opening is for weekend call coverage from Friday evening at 5pm to Monday morning at 8am.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17779&refsrc=dh

Visit MedJobs Today.com to search for a new job!

CROI Meeting

CROI: Atazanavir Equals Lopinavir in Head-On Contest

CROI: Extended HIV Treatment for Babies Reduces Breast-Milk Risk

SABCS Meeting

SABCS: Optimizing Breast Cancer Treatment with Biologics

SABCS: A Call to Scrap Anthracyclines for Breast Cancer

ACG Meeting

ACG: Weight Gain with Infliximab in Crohn's Disease Confirmed but Not Explained

ACG: Natalizumab Demonstrates Activity in Crohn's Disease After
Anti-TNF Failure

AHA Meeting

AHA: Step Care Hypertension Algorithm Gets Patients to Goals

AHA: Women Have More Complications than Men with ICD Implants

Get tools, resources & information about Gleevec matching the experience of attendees of the 2007 ASH Annual Meeting.

Did you miss the Gleevec booth at the 2007 ASH Meeting? Get tools, resources and information about Gleevec via a fully interactive virtual exhibit booth, matching the experience of attendees of the 2007 ASH Annual Meeting.

Source: Novartis Oncology.

At MedPage Today™, we’re PUTTING BREAKING MEDICAL NEWS INTO PRACTICE™.

You have received this email because you have registered to receive alert emails at www.medpagetoday.com, with the email address: delphine1939@videotron.ca. You can easily manage your subscriptions by clicking on the "Edit Profile" link below.

SUBSCRIBE OR UNSUBSCRIBE:
Edit Profile

TECHNICAL QUESTIONS:
webmaster@medpagetoday.com

MedPage Today, LLC.
Overlook at Great Notch
150 Clove Road
Little Falls, New Jersey 07424
Telephone: (973) 890-0985
Fax: (973) 890-1327